AGIO Bathi resik saben saham sajrone 12 wulan pungkasan agios.com

This chart, where the current level is -6.27, confirms the financial resilience of Agios Pharmaceuticals (AGIO) driven by oncology royalties and liquid reserves. The rolling annual earnings per share value is based on the firm's leadership in pyruvate kinase deficiency therapy for orphan patients. Meanwhile, the moderate predictability of cash flows depends directly on the development of new drugs and market competition.

AGIO (Agios Corp) riwayat Bathi resik saben saham (EPS TTM) saka 04.07.2022 nganti 15.11.2026

Rincian analitis lan laporan data perusahaan Agios Corp (AGIO)

- rega saham lan target rega konsensus:

Rega saham Agios Corp|AGIO - Rata-rata rega prakiraan

- data kapitalisasi pasar:

Biji pasar Agios Pharmaceuticals, Inc.|AGIO - Total Nilai Bisnis

- indikator nilai aset resik miturut neraca:

Nilai Buku saben Saham Agios Pharmaceuticals|AGIO - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku agios.com|AGIO - Aset Agregat Perusahaan

- rincian struktur utang lan likuiditas bisnis:

Utang marang Ekuitas Agios Pharmaceuticals|AGIO - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Agios Pharmaceuticals|AGIO - Utang perusahaan|Utang-utang marang kapitalisasi buku Agios Pharmaceuticals|AGIO - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Agios Pharmaceuticals|Likuiditas cepet agios.com

- indikator pendapatan resik lan kelipatan nilai:

AGIO - Penghasilan resik|Proyeksi bathi mangsa ngarep Agios Pharmaceuticals|AGIO - Pangali P/E|Pangali Forward P/E Agios|AGIO - Rasio rega marang wutah bathi resik|Pangali EV/EBITDA Agios Pharmaceuticals|AGIO - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Agios Pharmaceuticals|AGIO - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan agios.com|AGIO - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Agios Pharmaceuticals

- data dodolan lan asil:

AGIO - Pendapatan dodolan perusahaan|Prakiraan pendapatan perusahaan Agios Pharmaceuticals|AGIO - Rasio rega marang dodolan|Multiplikator Forward P/S Agios Corp|AGIO - Dinamika pendapatan YoY sajrone rolas wulan kepungkur

Pambiji fundamental perusahaan:Agios (AGIO)

This metric reflects the rolling annual net income per share, allowing for an assessment of business capitalization efficiency and its ability to generate real income. For Agios Pharmaceuticals (AGIO), which possesses a monopoly platform for rare disease therapy, the 12-month net income per share chart demonstrates the financial results of a lack of market alternatives and resilient demand.

Pesaing Agios Pharmaceuticals